India Stocks Close at New Record on Vaccine, Earnings Prospects
(Bloomberg) -- India stocks advanced to new highs as sentiment was boosted by a positive start to the quarterly earnings season and the commencement of vaccinations in the nation this week.
The S&P BSE Sensex climbed 1% to 49,269.3 in Mumbai, while the NSE Nifty 50 Index also advanced 1%. Both gauges were boosted by technology companies after Tata Consultancy Services Ltd. posted earnings that beat expectations. A jump in vehicle registrations also fueled expectations of a strong quarter for carmakers.
“December quarter results look promising and have been boosted by a recovery in the economy,” said Deven Choksey, a strategist at KRChoksey Investment Managers Pvt. in Mumbai, “The start of the vaccination drive is positive for sentiment and is continuing globally.”
India’s stocks have benefited from foreign investors piling in amid signs of recovery in the economy, even as it heads for its worst annual contraction since the 1950s. As the world’s top hot spot for coronavirus infections after the U.S., deployment of vaccinations from the end of this week is seen speeding a revival in growth.
Tata Consultancy climbed 1.7% to a record high after Asia’s largest software outsourcing provider posted net income and sales that beat analysts’ estimates and forecast double digit growth next financial year. Infosys Ltd. and Wipro Ltd., both due to report results on Wednesday, each climbed more than 3%.
The yield on the benchmark 10-year government bond increased by four basis points to 5.92%, while the rupee weakened 0.2% to 73.3850 per U.S. dollar.
- Twelve of 19 sector sub-indexes compiled by BSE Ltd. advanced, led by a gauge of IT companies
- Twenty Sensex shares rose while 10 fell
- Infosys Ltd. contributed most to the advance, climbing 4.9%; HCL Technologies Ltd. saw the steepest jump, rising 6.1%
- Analysts Are Now Bullish on 70% of Equities in Asia: Chart
- RBI’s Cash Tightening to Spark Recovery in Money-Market Rates
©2021 Bloomberg L.P.